NCT02989298 Peritoneal Dialysis Registration System (PERSIST)
| NCT ID | NCT02989298 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sun Yat-sen University |
| Condition | ESRD |
| Study Type | OBSERVATIONAL |
| Enrollment | 10,000 participants |
| Start Date | 2013-12 |
| Primary Completion | 2030-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 10,000 participants in total. It began in 2013-12 with a primary completion date of 2030-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Brief Summary: The investigators are registering all PD patients at recruited hospitals and developing a PD database in China. Patients will be followed up every 3 months, and both baseline and follow-up information will be collected and input into the registration system. The patient survival, technical survival, peritonitis rate, longitudinal changes of residual renal function and peritoneum function, and quality of life for PD patients, etc, will be compared using the PD database.
Eligibility Criteria
Inclusion Criteria:PD patients - Exclusion Criteria:No \-
Contact & Investigator
Xueqing Yu, M.D. & Ph.D.
PRINCIPAL INVESTIGATOR
First Affiliated Hospital, Sun Yat-Sen University
Frequently Asked Questions
Who can join the NCT02989298 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying ESRD. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02989298 currently recruiting?
Yes, NCT02989298 is actively recruiting participants. Contact the research team at yuxq@mail.sysu.edu.cn for enrollment information.
Where is the NCT02989298 trial being conducted?
This trial is being conducted at Guangzhou, China.
Who is sponsoring the NCT02989298 clinical trial?
NCT02989298 is sponsored by Sun Yat-sen University. The principal investigator is Xueqing Yu, M.D. & Ph.D. at First Affiliated Hospital, Sun Yat-Sen University. The trial plans to enroll 10,000 participants.